-- 据Aegis Hedging分析师Christian Drolshagen周四在一份报告中指出,受数据中心和人工智能基础设施快速扩张的推动,美国电力需求持续增长,但对天然气消费的影响可能会有所延迟。 Drolshagen表示,可再生能源的增长预计将抵消近期电力需求的大部分增长,从而限制天然气发电的上涨空间。 预计未来几年,美国本土48个州的电力消耗将温和增长。 美国能源信息署预测,2026年夏季的电力需求将比2025年增长约2%,2027年预计将增长3.4%。 尽管存在这种上升趋势,Drolshagen指出,太阳能和公用事业规模电池储能装置的激增正在重塑发电结构。 太阳能发电容量持续快速增长,在白天与天然气直接竞争,而电池储能装置在夜间越来越多地取代效率较低的燃气调峰电厂。因此,假设气候条件正常,预计今年夏季电力行业的天然气需求将与2025年水平持平或略有下降。然而,高于平均水平的气温仍可能因制冷需求增加而推高天然气需求。 展望未来,2027年后前景将发生变化,届时电力需求增长预计将开始超过可再生能源新增装机容量。这种动态变化可能导致电力行业天然气消费量小幅增长。 报告指出,与此同时,液化天然气出口需求的增长预计将推高原料气需求,这可能在本十年末支撑美国天然气价格。
Related Articles
Research Alert: Bio: Q1 Results Above Estimates Despite Meaningful Sales/margin Compression
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:BIO delivered Q1 results showing pressure across both segments, with revenue of $592.1M growing 1.1% Y/Y (~$3M above consensus) but declining 4.2% currency neutral. Adjusted EPS of $1.89 fell 25.6% Y/Y yet beat consensus by $0.10, while operating margin deteriorated 420 bps to 6.6% from 10.8% in the prior year. Both Life Science and Clinical Diagnostics segments experienced currency neutral declines due to ongoing academia weakness and Middle East conflicts. Management lowered 2026 guidance, expecting currency neutral revenue of -3.0% to +0.5% growth (down from +0.5% to +1.5%) and operating margin of 10.0%-12.0% (vs. prior 12.0%-12.5%). Despite operational headwinds, BIO maintained strong cash generation with $78.1M in FCF and repurchased ~176K shares. The company's balance sheet remains healthy, with $1.56B in cash and short-term investments, providing financial flexibility amid challenging market conditions, in our view.
ResMed Posts Higher Fiscal Q3 Non-GAAP Earnings, Revenue
ResMed (ASX:RMD) reported Friday fiscal third-quarter non-GAAP earnings of $2.86 per share, up from $2.37 a year earlier.Analysts polled by FactSet expected earnings of $2.80.Revenue for the three months ended March 31 was $1.43 billion, compared with $1.29 billion a year earlier. Analysts surveyed by FactSet expected $1.42 billion.The company expects its fiscal 2026 non-GAAP gross margin to be between 62% and 63%.The board declared a quarterly dividend of $0.60 per share, up from $0.53 a year earlier, payable June 18 to shareholders on record as of May 14.
Research Alert: Gddy: Strong Profitability Metrics Offset By Continued Revenue Headwinds
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:GDDY posted Q1 2026 revenue of $1.2B (+6%), in line with consensus, with EPS of $1.60 beating estimates of $1.52 despite booking deceleration to +2.7% from +5% in Q4. A&C segment growth of +11.6% to $498M showed resilience but continued moderating, while Core Platform remained sluggish at +2.8%. We view booking weakness as concerning given competitive pressures and small business spending constraints that raise questions about growth sustainability. Management reaffirmed 2026 revenue guidance of $5.195B-$5.275B (~6% growth), reflecting limited visibility into booking improvement. However, we see encouraging AI monetization signs with ARPU growth of +9.3% to $246 and Airo AI Builder achieving multi-million dollar annualized bookings within weeks of beta launch. We believe GDDY's impressive margin expansion with NEBITDA margins reaching 32.6% (+210 bps) demonstrates operational discipline, though sustaining A&C growth above 10% remains critical for investor confidence.